HeartWare vote for US move

By Dylan Bushell-Embling
Wednesday, 17 September, 2008

Medical device company HeartWare [ASX: HTW] has received federal court approval to go ahead with shareholder meetings to vote on its plans to redomicile in the US.

Meetings are planned for October 22.

HeartWare has appointed BDO Kendalls Corporate Finance (QLD) to independently assess the proposed scheme. BDO has determined that the scheme is in the best interest of all stockholders.

Indigenous-led initiative to resurrect the South Island Giant Moa

New Zealand's Ngāi Tahu Research Centre has partnered with Colossal Biosciences and Sir Peter...

Abnormal brain protein targeted in Parkinson's study

Researchers have identified a new brain protein involved in the development of Parkinson's...

Epilepsy disease model treated in a laboratory dish

A research team has used an epilepsy-like disease model in a laboratory dish to demonstrate that...

Content from other channels on our network

Ferrero to acquire WK Kellogg Co for US$3.1bn

AFGC's videos busting myths about processed food

AIP flexible packaging training at Foodtech Packtech

OD200: New Compact Distance Sensor Raising the Bar in Performance and Reliability

Heat and Control expands thermal range with Tek-Dry acquisition

Suntory Oceania's $3bn beverage business launched in Qld

Bega Group to close peanut processing business

Konica Minolta and MiR launching two autonomous robots at CeMat

Researchers achieve brine concentration using waste heat or sunlight

ARENA backs Orica on renewable hydrogen production

City of Gosnells develops tree production nursery

Experts warn against health risks of plastic pollution

Blue Connections IT achieves carbon neutrality through sustainable technology

How real-world events underscore the urgency of climate disclosures

Kur-ring-gai receives kerbside EV charging